SpringWorks Therapeutics Stock
SpringWorks is a medicines company.
Sign up today and learn more about SpringWorks Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About SpringWorks Therapeutics Stock
They are a different type of therapeutic development company purpose-built for the 21st century. SpringWorks Therapeutics is on a mission to connect scientists, biopharmaceutical partners, patient groups, funders and philanthropists to deliver promising, transformative science to underserved patients. Their name symbolizes their mission-driven approach to therapeutic development—they’re springing into action to deliver treatments to people who are in urgent need.
Funding History
| September 2017 | $103M |
|---|
Management
President and Founder
Lara S. Sullivan
Executive Chairman
Daniel S. Lynch
Chief Financial Officer and Chief Business Officer
Saqib Islam
Press
Business Wire (press release) - Mar, 5 2018
SpringWorks Therapeutics to Present at Cowen and Company's 38Baltimore Business Journal - Feb, 2 2018
These Maryland companies received the most venture capital in 2017MedCity News - Sep, 29 2017
Pfizer spin-off SpringWorks embraces shelved therapiesHIT Consultant - Sep, 27 2017
Pfizer Spin Off Lands $103M to Develop New Drugs for Undeserved Patient PopulationsEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
